Survey of Predictors of Human Papillomavirus (HPV) Vaccination Among Parents of Rural Adolescent Girls in Mysore, India

October 28, 2014 updated by: Purnima Madhivanan

Survey of Predictors of HPV Vaccination Among Parents of Rural Adolescent Girls in Mysore, India

To conduct a quantitative survey to measure knowledge about Human papillomavirus (HPV) and cervical cancer, and HPV vaccine acceptability among parents of rural adolescent girls in Mysore District, India.

Hypothesis: General knowledge and attitudes about the severity and treat ability of cancer will predict acceptability of HPV vaccination among parents of rural adolescent girls in Mysore, India.

Study Overview

Status

Unknown

Study Type

Observational

Enrollment (Anticipated)

800

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Karnataka
      • Mysore, Karnataka, India, 560020
        • Recruiting
        • Public Health Research Institute of India
        • Contact:
      • Mysore, Karnataka, India, 570020
        • Recruiting
        • Public Health Research Institute of India
        • Contact:
        • Contact:
        • Sub-Investigator:
          • Vijaya Srinivas, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 55 years (ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

The study will survey attitudes of parents of adolescent girls attending 10 schools in rural Mysore Taluk in Mysore District.

Description

Inclusion Criteria:

  • over 18 years of age
  • parent of an adolescent girl (10 -15 years of age)
  • able to speak English or Kannada
  • willing to undergo informed consent process

Exclusion Criteria:

  • Does not have the capacity to undergo informed consent process

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Parental Acceptability of HPV vaccine
Time Frame: One year
One year

Secondary Outcome Measures

Outcome Measure
Time Frame
Knowledge about HPV and Cervical Cancer
Time Frame: One Year
One Year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Purnima Madhivanan, MBBS, PhD, Public Health Research Institute of India

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2014

Primary Completion (ANTICIPATED)

June 1, 2015

Study Completion (ANTICIPATED)

December 1, 2015

Study Registration Dates

First Submitted

March 2, 2011

First Submitted That Met QC Criteria

March 2, 2011

First Posted (ESTIMATE)

March 3, 2011

Study Record Updates

Last Update Posted (ESTIMATE)

October 29, 2014

Last Update Submitted That Met QC Criteria

October 28, 2014

Last Verified

October 1, 2014

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cervical Cancer

Subscribe